Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patients

Completed

• Conditions: Catheter-related infections; Infections and Infestations

• Registration Number: ISRCTN86885538
• Lead Sponsor: Tauropharm (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-16
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Paediatric patients with newly implanted central venous catheters

Exclusion Criteria

Bacteremia/sepsis ongoing; allergy against heparin or taurolidine

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bacterial growth/biofilm formation in removed catheters

Secondary Outcome Measures

Name	Time	Method
Catheter-related infections, catheter occlusions